Alterations in gene expression of proteins involved in the calcium handling in patients with atrial fibrillation

Journal of Cardiovascular Electrophysiology

Volumn 10, Issue 4, 1999, Pages 552-560

  Van Gelder, Isabelle C ^a   Brundel, Bianca J J M ^a   Henning, Robert H ^a   Tuinenburg, Anton E ^a   Tieleman, Robert G ^a   Deelman, Leo ^a   Grandjean, Jan G ^a   De Kam, Pieter Jan ^a   Van Gilst, Wiek H ^a   Crijns, Harry J G M ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Atrial fibrillation; Calcium channels; Sarcoplasmic reticulum

Indexed keywords

ADENOSINE TRIPHOSPHATASE; CALCIUM CHANNEL; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MESSENGER RNA; PHOSPHOLAMBAN;

ADULT; AGED; ARTICLE; CALCIUM CELL LEVEL; CHANNEL GATING; CLINICAL ARTICLE; FEMALE; GENE EXPRESSION REGULATION; HEART ATRIUM CONTRACTION; HEART ATRIUM FIBRILLATION; HEART MUSCLE POTENTIAL; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SARCOPLASMIC RETICULUM; SINUS RHYTHM; SODIUM CALCIUM EXCHANGE;

EID: 0032908339     PISSN: 10453873     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8167.1999.tb00712.x     Document Type: Article

References (55)

1. 1. Kannel WB, Abbott RD, Savage DD, et al: Epidemiologic features of chronic atrial fibrillation. N Engl J Med 1982;306:1018-1022.
2. 2. Önundarson PT, Thorgeirsson G, Jonmundsson E, et al: Chronic atrial fibrillation-epidemiologic features and 14 years follow-up: A case control study. Eur Heart J 1987;8:521-527.
3. 3. Krahn AD, Manfreda J, Tate RB, et al: The natural history of atrial fibrillation: Incidence, risk factors, and prognosis in the Manitoba follow-up study. Am J Med 1995;98:476-484.
4. 4. Godtfredsen J: Atrial fibrillation. Etiology, course and prognosis. A follow-up study of 1212 cases. Copenhagen: University of Copenhagen, 1975. (Thesis).
5. 5. Bjerkelund C, Orning OM: An evaluation of DC shock treatment of atrial arrhythmias. Acta Med Scand 1968; 184:481-491.
6. 6. Van Gelder IC, Crijns HJGM, Tieleman RG, et al: Value and limitation of electrical cardioversion in patients with chronic atrial fibrillation - importance of arrhythmia risk factors and oral anticoagulation. Arch Intern Med 1996;156:2585-2592.
7. 7. Sopher SM, Camm AJ: Atrial fibrillation - maintenance of sinus rhythm versus rate control. Am J Cardiol 1996;77:24A-38A.
8. 8. Graettinger JS, Carleton RA, Muenster JJ: Circulatory consequences of changes in cardiac rhythm produced in patients by transthoracic direct-current shock. J Clin Invest 1964;43:2290-2302.
9. 9. Braunwald E: Symposium on cardiac arrhythmias: Introduction with comments on the hemodynamic significance of atrial systole. Am J Med 1964;37:665-669.
10. 10. Leistad E, Aksnes G, Verburg E, et al: Atrial contractile dysfunction after short-term atrial fibrillation is reduced by verapamil but increased by BAY K8644. Circulation 1996;93:1747-1754.
11. 11. Manning WJ, Silverman DI, Katz SE, et al: Impaired left atrial mechanical function after cardioversion: Relation to duration of atrial fibrillation. J Am Coll Cardiol 1994;23:1535-1540.
12. 12. Sun H, Gaspo R, Leblanc N, et al: Cellular mechanism of atrial contractile dysfunction caused by sustained atrial tachycardia. Circulation 1998;98:719-727.
13. 13. Shapiro EP, Effron MB, Lima S, et al: Transient atrial dysfunction after conversion of chronic atrial fibrillation to sinus rhythm. Am J Cardiol 1988;62:1202-1207.
14. 14. Gallagher MM, Obel OA, Camm AJ: Tachycardia-induced atrial myopathy: An important mechanism in the pathology of atrial fibrillation? J Cardiovasc Electrophysiol 1997;8:1065-1074.
15. 15. Ausma J, Wijffels M, Thon JF, et al: Structural changes of atrial myocardium due to sustained atrial fibrillation in the goat. Circulation 1997;96:3157-3163.
16. 16. Morillo CA, Klein GJ, Jones DL, et al: Chronic rapid atrial pacing: Structural, functional and electrophysiologic characteristics of a new model of sustained atrial fibrillation. Circulation 1995;91:1588-1595.
17. 17. Bailey GW, Braniff BA, Hancock W, et al: Relation of left atrial pathology to atrial fibrillation in mitral valvular disease. Ann Intern Med 1968;69:13-20.
18. 18. Davies MJ, Pomerance A: Pathology of atrial fibrillation in man. Br Heart J 1972;34:520-525.
19. 19. Mary-Rabine L, Pham TD, Hordof A, et al: The relationship of human atrial cellular electrophysiology to clinical function and ultrastructure. Circ Res 1983;52: 188-199.
20. 20. Lee H-C, Clusin WT: Cytosolic calcium staircase in cultured myocardial cells. Circ Res 1987;61:934-939.
21. 2+ current in frog ventricular myocytes by the holding potential, c-AMP and frequency. Pflügers Arch 1989;415:1-11.
22. 22. De Pauw M, Borgers M, Heyndrickx GR: Ultrastructural calcium distribution in cardiac myocytes after 48h of rapid pacing in dogs. (Abstract) Circulation 1996; 94:I-604.
23. 23. Yue L, Feng J, Gaspo R, et al: Ionic remodeling underlying action potential changes in a canine model of atrial fibrillation. Circulation 1997;81:512-525.
24. 24. Van Wagoner DR, Lamorgese M, Kirian P, et al: Calcium current density is reduced in atrial myocytes isolated from patients in chronic atrial fibrillation. (Abstract) Circulation 1997;96:I-180.
25. 25. Chelly J, Montarras D, Pinsel C, et al: Quantitative estimation of minor mRNAs by cDNA polymerase chain reaction - application to dystrophin mRNA in cultured myogenic and brain cells. Eur J Biochem 1990;187: 691-698.
26. 26. Noonan KE, Beck C, Holzmayer TA, et al: Quantitative analysis of MDR1 (multi drug resistance) gene expression in human tumors by polymerase chain reaction. Proc Natl Acad Sci U S A 1990;87:7160-7164.
27. 27. Cox JL, Jaquiss RD, Schuessler RB, et al: Modification of the maze procedure for atrial flutter and atrial fibrillation. II. Surgical technique of the maze III procedure. J Thorac Cardiovasc Surg 1995;110:485-495.
28. 28. Goette A, Honeycutt C, Langberg JJ: Electrical remodeling in atrial fibrillation. Time course and mechanisms. Circulation 1996;94:2968-2974.
29. 29. Daoud EG, Knight BP, Weiss R, et al: Effect of verapamil and procainamide on atrial fibrillation - induced electrical remodeling in humans. Circulation 1997;96: 1542-1550.
30. 30. Tieleman RG, De Langen CDJ, Van Gelder IC, et al: Verapamil reduces tachycardia induced electrical remodeling of the atria. Circulation 1997;95:1945-1953.
31. 31. Tieleman RG, Van Gelder IC, Crijns HJGM, et al: Early recurrences of atrial fibrillation after electrical cardioversion: a result of fibrillation-induced electrical remodeling of the atria? J Am Coll Cardiol 1998;31: 167-173.
32. 32. Wijffels MCEF, Kirchhof CJHJ, Dorland R, et al: Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation 1995;92:1954-1968.
33. + current in a chronic dog model of atrial fibrillation. Circ Res 1997;81:1045-1052.
34. 34. Yue L, Wang Z, Gaspo R, et al: The molecular mechanism of ionic remodeling of repolarization in a dog model of atrial fibrillation. (Abstract) Circulation 1997; 96:I-180.
35. 35. Le Grand B, Hatem S, Deroubaix E, et al: Depressed transient outward and calcium currents in dilated human atria. Cardiovasc Res 1994;28:548-556.
36. 36. Ouadid H, Albat B, Nargeot J: Calcium currents in diseased human cardiac cells. J Cardiovasc Pharmacol 1995;25:282-291.
37. + current densities and Kv1.5 expression are reduced in chronic human atrial fibrillation. Circ Res 1997;80:772-781.
38. 38. Shinbane JS, Wood MA, Jensen N, et al: Tachycardia-induced cardiomyopathy: A review of animal models and clinical studies. J Am Coll Cardiol 1997;29:709-715.
39. 39. Spinale FG, Tanaka R, Crawford FA, et al: Changes in myocardial blood flow during development of and recovery from tachycardia-induced cardiomyopathy. Circulation 1992;85:717-729.
40. i during pacing-induced heart failure. Circulation 1996;94:102-107.
41. 41. Colston JT, Kumar P, Chambers JP, et al: Altered sarcolemmal calcium channel density and calcium-pump ATPase activity in tachycardia heart failure. Cell Calcium 1994;16:349-356.
42. 2+ cycle in congestive heart failure produced in dogs by idiopathic dilated cardiomyopathy and rapid ventricular pacing. J Mol Cell Cardiol 1994;26:173-184.
43. 43. Hasenfuss G: Alterations of calcium-regulatory proteins in heart failure. Cardiovasc Res 1998;37:279-289.
44. 44. Mukherjee R, Hewett KW, Walker JD, et al: Changes in L-type calcium channel abundance and function during transition to pacing-induced congestive heart failure. Cardiovasc Res 1998;37:432-444.
45. 2+ channel) and calsequestrin genes in the myocardium of patients with end-stage heart failure. J Clin Invest 1992;90:927-935.
46. 2+ exchanger in end-stage human heart failure. Circ Res 1994;75:443-453.
47. 2+-ATPase activity of sarcoplasmic reticulum from dilated cardiomyopathy patients compared with patients with nonfailing hearts. Circulation 1995;92:3220-3228.
48. 48. Flesch M, Schwinger RHG, Schnabel P, et al: Sarcoplasmic reticulum calcium ATPase and phospholamban mRNA and protein levels in end-stage heart failure due to ischemic or dilated cardiomyopathy. J Mol Med 1996;74:321-332.
49. 2+-ATPase in failing and nonfailing human hearts. Cardiovasc Res 1996;31:625-632.
50. 50. Movsesian MA, Schwinger RHG: Calcium sequestration by the sarcoplasmic reticulum in heart failure. Cardiovasc Res 1998;37:352-359.
51. 2+ exchanger in failing human myocardium. Circulation 1996;94:992-1002.
52. 52. De Tombe PP: Altered contractile function in heart failure. Cardiovasc Res 1998;37:367-380.
53. 53. Dixon IMC, Lee SL, Dhalla NS: Nitrendipine binding in congestive heart failure due to myocardial infarction. Circ Res 1990;66:782-788.
54. 54. Schwinger RHG, Böhm M, Pieske B, et al: Different β-adrenoceptor-effector coupling in human ventricular and atrial myocardium. Eur J Clin Invest 1991;21:443-451.
55. 2+ channels is sensitive to cytoplasmic calcium. Pflügers Arch 1992;421:516-518.